|Day Low/High||160.59 / 162.74|
|52 Wk Low/High||74.37 / 165.93|
Zimmer Biomet's move to acquire LDR Holding is a smart one and it also bodes well for another medical device company NuVasive, said TheStreet's Jim Cramer.
This market has taken some frantic turns from one group to the other.
Candidates have decried rising drug and medical prices, but there are reasons to like these stocks.
Favorable fourth-quarter results are just the beginning; management exudes confidence.
AbbVie, Teva and Zimmer Biomet posted solid quarters and are upbeat about the road ahead.
Problems with acquisition resolved, key name in orthopedics has its best outlook in years.
Value investing has had a rough year, but 2016 should be better. These stocks can help.